Intervention Diagnostics, Inc. (IVD), is privately funded healthcare R&D company specializing in the development of electrochemical sensors for the medical diagnostics industry.  Our President, Jim Connolly, founded the company which became operational in 2005.

Jim Connolly has over 30 years of experience in developing electrochemical sensors in the diabetes care market and continues to lead the company as we develop new and innovative products supported by many patents.  IVD’s mission is to complement the extensive global testing market by developing a range of sensors for high-impact diagnostic tools that help diagnose key blood chemistries that support both general health and the many medical complications that result from diabetes. With this focus, the market opportunity for IVD is enormous.

Other key benefits of the blood test technologies being developed at IVD are lower costs and speed of results.  The tests IVD is developing will replace current centralized lab testing that currently requires expensive equipment and infrastructure.  All of IVD’s tests are designed to provide results within seconds from a single drop of blood.